Betacetylmethadol

Betacetylmethadol

Systematic (IUPAC) name
(3S,6R)-6-(dimethylamino)-4,4-diphenyl-3-heptanyl acetate
Clinical data
Legal status
Legal status	AU: S9 (Prohibited) CA: Schedule I DE: Anlage I (Controlled) US: Schedule I
Identifiers
CAS Number	17199-59-6
ATC code	None
PubChem	CID 62710
DrugBank	DB01522
ChemSpider	56457
ChEMBL	CHEMBL2105619
Chemical data
Formula	C23H31NO2
Molar mass	353.498 g/mol
SMILES O=C(O[C@H](C(c1ccccc1)(c2ccccc2)C[C@H](N(C)C)C)CC)C
InChI InChI=1S/C23H31NO2/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h7-16,18,22H,6,17H2,1-5H3/t18-,22+/m1/s1 Key:XBMIVRRWGCYBTQ-GCJKJVERSA-N

Betacetylmethadol is a synthetic opioid.^[1] It is a diastereoisomer of alphacetylmethadol (as well as levacetylmethadol).^[1] In the United States, betacetylmethadol is a Schedule I drug Narcotic under the Controlled Substances Act, with an ACSCN of 9607 and a 2 gramme manufacturing quota as of 2014.^[2]

See also

• Acetylmethadol
• Alphacetylmethadol
• Levacetylmethadol
• Betamethadol

References

1. Newman JL, Vann RE, May EL, Beardsley PM (October 2002). "Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats". Psychopharmacology 164 (1): 108–14. doi:10.1007/s00213-002-1198-8. PMID 12373424.
2. 21 U.S.C. § 812(b)(1)